Johnson Matthey Future Growth

Future criteria checks 3/6

Johnson Matthey's revenue is forecast to decline at 43.3% per annum while its annual earnings are expected to grow at 28.4% per year. EPS is expected to grow by 31% per annum. Return on equity is forecast to be 12.7% in 3 years.

Key information

28.4%

Earnings growth rate

31.0%

EPS growth rate

Chemicals earnings growth	28.0%
Revenue growth rate	-43.3%
Future return on equity	12.7%
Analyst coverage	Good
Last updated	25 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:JMATL - Analysts future estimates and past financials data (GBP Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2027	3,749	322	216	602	5
3/31/2026	3,670	281	167	567	8
3/31/2025	3,694	261	346	563	8
3/31/2024	12,843	108	224	592	N/A
12/31/2023	13,490	143	135	487	N/A
9/30/2023	14,136	177	45	382	N/A
6/30/2023	14,535	221	10	337	N/A
3/31/2023	14,933	264	-25	291	N/A
12/31/2022	14,892	277	-46	315	N/A
9/30/2022	14,850	290	-68	338	N/A
6/30/2022	15,438	203	42	472	N/A
3/31/2022	16,025	116	152	605	N/A
9/30/2021	16,959	146	309	699	N/A
6/30/2021	16,197	170	349	734	N/A
3/31/2021	15,435	194	388	769	N/A
12/31/2020	15,206	154	597	1,004	N/A
9/30/2020	14,738	103	805	1,239	N/A
6/30/2020	14,658	179	480	919	N/A
3/31/2020	14,577	255	155	598	N/A
12/31/2019	13,587	320	15	431	N/A
9/30/2019	12,596	385	-126	263	N/A
6/30/2019	11,671	399	-46	299	N/A
3/31/2019	10,745	413	33	334	N/A
12/31/2018	9,754	373	46	312	N/A
9/30/2018	8,763	333	59	290	N/A
6/30/2018	9,519	316	115	338	N/A
3/31/2018	10,274	298	170	386	N/A
12/31/2017	11,579	338	N/A	397	N/A
9/30/2017	12,884	377	N/A	407	N/A
6/30/2017	12,458	382	N/A	465	N/A
3/31/2017	12,031	386	N/A	523	N/A
12/31/2016	11,307	308	N/A	484	N/A
9/30/2016	10,584	231	N/A	445	N/A
6/30/2016	10,649	282	N/A	656	N/A
3/31/2016	10,714	333	N/A	867	N/A
12/31/2015	10,864	434	N/A	687	N/A
9/30/2015	11,015	535	N/A	508	N/A
6/30/2015	10,537	482	N/A	317	N/A
3/31/2015	10,060	429	N/A	126	N/A
12/31/2014	9,802	384	N/A	260	N/A
9/30/2014	9,545	340	N/A	394	N/A
6/30/2014	10,350	340	N/A	435	N/A
3/31/2014	11,155	340	N/A	477	N/A
12/31/2013	11,701	321	N/A	488	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: JMATL's forecast earnings growth (28.4% per year) is above the savings rate (2.1%).

Earnings vs Market: JMATL's earnings (28.4% per year) are forecast to grow faster than the UK market (14.6% per year).

High Growth Earnings: JMATL's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: JMATL's revenue is expected to decline over the next 3 years (-43.3% per year).

High Growth Revenue: JMATL's revenue is forecast to decline over the next 3 years (-43.3% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: JMATL's Return on Equity is forecast to be low in 3 years time (12.7%).

Johnson Matthey Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Johnson Matthey PLC Provides Earnings Guidance for the Year Ending 31 March 2025

Johnson Matthey Plc Provides Operating Guidance for the Year Ended March 31, 2021

Recent updates

Johnson Matthey Plc(LSE:JMAT) dropped from FTSE All-World Index (USD)

Johnson Matthey plc Announces Board and Committee Changes

Johnson Matthey Plc Declares a Final Dividend

Johnson Matthey Plc (LSE:JMAT) announces an Equity Buyback for £250 million worth of its shares.

Montagu Private Equity LLP acquired Medical Device Components business from Johnson Matthey Plc (LSE:JMAT).

Johnson Matthey plc Announces Stephen Oxley, Chief Financial Officer to Step Down

Final dividend of UK£0.55 announced

Johnson Matthey PLC Provides Earnings Guidance for the Year Ending 31 March 2025

Full year 2024 earnings released: EPS: UK£0.59 (vs UK£1.44 in FY 2023)

Johnson Matthey Plc to Report First Half, 2025 Results on Nov 27, 2024

First half 2024 earnings released: EPS: UK£0.34 (vs UK£0.82 in 1H 2023)

New minor risk - Financial position

Johnson Matthey Plc to Report Fiscal Year 2024 Results on May 23, 2024

New minor risk - Shareholder dilution

Johnson Matthey Plc(LSE:JMAT) dropped from FTSE 100 Index

Johnson Matthey plc Approves Final Dividend

Johnson Matthey Plc to Report First Half, 2024 Results on Nov 23, 2023

Johnson Matthey Reportedly Plans to Sell Medical Device Unit

Upcoming dividend of UK£0.55 per share at 4.4% yield

Full year 2023 earnings released: EPS: UK£1.44 (vs UK£0.61 in FY 2022)

Johnson Matthey plc Proposes Final Ordinary Dividend, Payable on August 1, 2023

Souter Investments Limited and Sullivan Street Partners Ltd agreed to acquire Diagnostic Services Business of Johnson Matthey Plc for £55 million.

Souter Investments Limited and Sullivan Street Partners Ltd agreed to acquire Diagnostic Services Business of Johnson Matthey Plc for £55 million.

Johnson Matthey Plc(LSE:JMAT) dropped from FTSE 250 Index

Upcoming dividend of UK£0.22 per share

Johnson Matthey plc Declares Interim Dividend,Payable on 1 February 2023

First half 2023 earnings released: EPS: UK£0.82 (vs UK£0.14 loss in 1H 2022)

Johnson Matthey Plc to Report Fiscal Year 2023 Results on May 26, 2023

Nano One Materials Corp. (TSX:NANO) completed the acquisition of Johnson Matthey Battery Materials Ltd from Johnson Matthey Plc (LSE:JMAT).

Johnson Matthey plc Approves a Final Dividend

Altaris Capital Partners, LLC acquired 70% stake in Veranova for £325 million.

Upcoming dividend of UK£0.55 per share

Altaris Capital Partners, LLC acquired 70% stake in Veranova.

Full year 2022 earnings released: EPS: UK£0.60 (vs UK£1.06 in FY 2021)

Johnson Matthey Plc to Report First Half, 2023 Results on Nov 23, 2022

Nano One Materials Corp. (TSX:NANO) signed a definitive agreement to acquire Johnson Matthey Battery Materials Ltd for CAD 10.25 million.

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Fenzi Holdings SPV S.p.A acquired Advanced Glass Technologies Business from Johnson Matthey Plc (LSE:JMAT).

Johnson Matthey Provides Update on Its Intention to Exit Battery Materials

Independent Non-Executive Director recently bought UK£52k worth of stock

CEO & Executive Director recently bought UK£97k worth of stock

Johnson Matthey Plc (LSE:JMAT) commences an Equity Buyback Plan for 19,353,343 shares, representing 10% of its issued share capital, under the authorization approved on July 29, 2021.

Johnson Matthey Plc(LSE:JMAT) dropped from FTSE 100 Index

Altaris Capital Partners, LLC entered into an agreement to acquire 70% stake in Health Business of Johnson Matthey Plc (LSE:JMAT) for £250 million.

Tata Chemicals Reportedly in Talks with Johnson Matthey

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

High number of new directors

Full year 2021 earnings released: EPS UK£1.06 (vs UK£1.33 in FY 2020)

Upcoming dividend of UK£0.50 per share

Full year 2021 earnings released: EPS UK£1.06 (vs UK£1.33 in FY 2020)

Johnson Matthey Plc Proposes Final Ordinary Dividend, Payable on August 3, 2021

Johnson Matthey Plc Provides Operating Guidance for the Year Ended March 31, 2021

New 90-day high: UK£30.83

Independent Non-Executive Director has left the company

Johnson Matthey and Envision Virgin Racing Announce Multi Year Strategic Partnership

New 90-day high: UK£30.00

Johnson Matthey plc Announces Executive Changes, Effective April 1, 2021

New 90-day high: UK£27.03

Johnson Matthey plc Announces Management Changes

Johnson Matthey Plc Appoints Eugene Mckenna as Business Head of Its Green Hydrogen Activities

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies